María Teresa Gómez‐Casares

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Andreas Hochhaus, Tamás Masszi, Francis J. Giles et al. · Leukemia · 2017 · 286 citations · Full text

Interactions between Tumor Necrosis Factor-α, Hypothalamic Corticotropin-Releasing Hormone, and Adrenocorticotropin Secretion in the Rat*

Renato Bernardini, Themis C. Kamilaris, Aldo E. Calogero et al. · Endocrinology · 1990 · 232 citations

Hypothalamic Corticotropin-releasing Hormone, Immunology, Immune Regulation +23

Clinical and therapeutic features of myasthenia gravis in adults based on age at onset

Elena Cortés‐Vicente, Rodrigo Álvarez‐Velasco, Sonia Segovia et al. · Neurology · 2020 · 159 citations · Full text

Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study

Neil P. Shah, Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 146 citations · Full text

Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation

Alberto Álvarez‐Larrán, Arturo Pereira, Paola Guglielmelli et al. · Haematologica · 2016 · 145 citations · Full text